CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 36 filers reported holding CONATUS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $7,000 | -12.5% | 21,000 | 0.0% | 0.00% | – |
| Q4 2019 | $8,000 | +14.3% | 21,000 | -4.5% | 0.00% | – |
| Q3 2019 | $7,000 | +16.7% | 22,000 | 0.0% | 0.00% | – |
| Q2 2019 | $6,000 | -75.0% | 22,000 | 0.0% | 0.00% | – |
| Q1 2019 | $24,000 | -36.8% | 22,000 | 0.0% | 0.00% | – |
| Q4 2018 | $38,000 | +2.7% | 22,000 | +238.5% | 0.00% | – |
| Q2 2017 | $37,000 | +5.7% | 6,500 | +8.3% | 0.00% | – |
| Q1 2017 | $35,000 | +34.6% | 6,000 | +20.0% | 0.00% | – |
| Q4 2016 | $26,000 | +160.0% | 5,000 | 0.0% | 0.00% | – |
| Q3 2016 | $10,000 | 0.0% | 5,000 | 0.0% | 0.00% | – |
| Q2 2016 | $10,000 | -9.1% | 5,000 | 0.0% | 0.00% | – |
| Q1 2016 | $11,000 | -21.4% | 5,000 | 0.0% | 0.00% | – |
| Q4 2015 | $14,000 | +250.0% | 5,000 | +400.0% | 0.00% | – |
| Q3 2015 | $4,000 | -42.9% | 1,000 | 0.0% | 0.00% | – |
| Q1 2015 | $7,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2014 | $7,000 | +16.7% | 1,000 | 0.0% | 0.00% | – |
| Q3 2014 | $6,000 | -33.3% | 1,000 | 0.0% | 0.00% | – |
| Q2 2014 | $9,000 | +12.5% | 1,000 | 0.0% | 0.00% | – |
| Q1 2014 | $8,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 1,192,080 | $9,704,000 | 4.11% |
| Ghost Tree Capital, LLC | 219,977 | $1,790,000 | 1.06% |
| JBF Capital, Inc. | 148,178 | $1,205,000 | 0.18% |
| Polar Capital LLP | 900,604 | $7,326,000 | 0.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 80,000 | $651,000 | 0.15% |
| HAMILTON LANE ADVISORS LLC | 33,141 | $270,000 | 0.11% |
| Jasper Ridge Partners, L.P. | 63,996 | $521,000 | 0.03% |
| Weiss Multi-Strategy Advisers LLC | 95,000 | $773,000 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 550,000 | $4,474,000 | 0.01% |
| AXA S.A. | 292,625 | $2,381,000 | 0.01% |